Normal Bone Marrow Inclusion Phenomena Induced by Lupus Erythematosus Plasma**From the Department of Dermatology, E.W. Netherton, M.D., Chief, and the Department of Medicine, A. Carlton Ernstene, M.D., Chief, Cleveland Clinic, Cleveland, Ohio.-Reference-Cited by-同舟云学术

Normal Bone Marrow Inclusion Phenomena Induced by Lupus Erythematosus Plasma**From the Department of Dermatology, E.W. Netherton, M.D., Chief, and the Department of Medicine, A. Carlton Ernstene, M.D., Chief, Cleveland Clinic, Cleveland, Ohio.

Published:1949-08 Issue:2 Volume:13 Page:47-49
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Haserick John R.,Bortz Donald W.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference5 articles.

1. Presentation of two bone marrow elements, the “Tart” cell and the “L. E.” cell;Hargraves;Proc. Staff Meet., Mayo Clinic,1948

2. The bone marrow as a diagnostic aid in acute disseminated lupus erythematosus;Haserick;J. Invest. Dermat.,1948

3. Personal communication to the authors;Sundberg;J. Invest. Dermat.,1949

4. Rapid methods for preparing and staining bone marrow;Schleicher;J. Lab. & Clin. Med.,1937

5. Evaluation of bone marrow techniques;Limarzi;J. Lab. & Clin. Med.,1947

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis;Lupus Science & Medicine;2024-01

2. Antinukleäre Antikörper in der Diagnostik rheumatischer Erkrankungen;Zeitschrift für Rheumatologie;2020-05-26

3. Terminology and definition of ‘antinuclear antibodies’: history and current debate;Annals of the Rheumatic Diseases;2020-03-30

4. Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis;Frontiers in Immunology;2019-01-14

5. Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus;Science Translational Medicine;2011-03-09